Best Biopharma Outsourcing Companies in Paris, France
The 41 best Biopharma Outsourcing companies in Paris, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Neovacs.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Paris
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Neovacs CDMO focused on manufacturing of vaccines | $18M | 92 mo ago | Public | Hugo Brugiere CEO | 1993 | JoomlaPHPUIKit+11 | 168 patents Cytokine-modulating immunogenic proteins and mRNA vaccines targeting IL‑4/IL‑13 pathways. | — |
| 2 | Biophta Developer of a pharmaceutical platform designed to transform ophthalmology by relieving patients from the… | $7M | 26 mo ago | Seed | Jean Garrec founder & CEO | 2020 | — | — | — |
| 3 | Generare Provider of drugs discovery services | $5M | 5 mo ago | Series A | Vincent Libis Co-Founder | 2022 | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | 1 job opening |
| 4 | L-up Provider of R&D funding program consulting and project management services | $4M | 68 mo ago | Funding Raised | Philippe Bellier Founder & Owner | 2001 | — | — | — |
| 5 | Iconeus Digital animal brain imaging and analysis device for researchers | $2M | 47 mo ago | Funding Raised | — | 2016 | WordPress Site EditorWordPressMySQL+20 | 25 patents Medical ultrasound systems for real-time brain vascular and physiological monitoring | — |
| 6 | Medexprim Provider of clinical research services for biopharma sector | $2M | 72 mo ago | Funding Raised | — | 2015 | — | — | — |
| 7 | Delpharm Pharmaceutical CDMO specialising in various finished dosage formulations | $969K | 62 mo ago | Funding Raised | — | 1988 | LeafletMUIReact+11 | 5 patents Injectable pharmaceutical formulations using phloroglucinol as active ingredient | 1 partnership |
| 8 | Unither Contract development and manufacturing organization for proprietary and generic drugs | $904K | 46 mo ago | Acquired | — | 1993 | WordPressMySQLPHP+24 | — | — |
| 9 | Xentech Patient-Derived tumor Xenograft patform offering preclinical cancer models and services for translational… | $765K | 128 mo ago | Seed | — | 2006 | — | 10 patents Identifying cancer biomarkers for predicting chemotherapeutic and PARP inhibitor response | — |
| 10 | Fareva CDMO offering formulation development, manufacturing and packaging solutions | $317K | 63 mo ago | Funding Raised | — | 1990 | PleskPHPZURB Foundation+7 | 4 patents Aerosol dispensing systems and nail‑polish removal devices | 1 partnership · 1 award |
| 11 | Medicen Paris Region Network supporting health innovation project development and funding | $311K | 48 mo ago | Funding Raised | Julien Ettersperger CEO | 2006 | WordPressWordPress Block EditorMySQL+19 | — | — |
| 12 | Novoptim Provider of marketing consulting services for biopharma sector | $205K | 81 mo ago | Funding Raised | — | 2006 | — | — | 1 award |
Top 12 Biopharma Outsourcing companies in Paris
#1
Series A · Paris, Ile de France · founded 2022$5.5Mraised▾
Provider of drugs discovery services
- Apr 2026Series A$23.3M
- Oct 2024Seed$5.5M
#2
Seed · Paris, Ile de France · founded 2020 · 3 employees$7.1Mraised▾
BIOPHTA is a pharmaceutical platform founded in 2020 that aims to improve the efficacy of eye treatments. The company has developed an ophthalmic insert to simplify eye treatment for patients with eye diseases.
- Jun 2024Seed$7.1M
#3
Public · Paris, Ile de France · founded 1993$17.9Mraised▾
CDMO focused on manufacturing of vaccines
- Dec 2018Post IPO$2.6M
- Jun 2017Post IPO$4.1M
- Jun 2016Post IPO$9.1M
- Jul 2015Post IPO$8.3M
#4
Funding Raised · Paris, Ile de France · founded 2001$3.7Mraised▾
Provider of R&D funding program consulting and project management services. It advises companies and research bodies on research funding and project management. The company supports project proposals, partner searches, collaborative proposal writing, and contractualization. It also provides support in project management, communication, training, data management, and exploitation of project results.
- Jan 2021Grant (prize money)$217.3K
- Oct 2020Grant (prize money)$246.6K
- Jan 2020Grant (prize money)$264.2K
- Jan 2020Grant (prize money)$758.5K
#5
Funding Raised · Paris, Ile de France · founded 2016 · 30 employees$1.8Mraised▾
Digital animal brain imaging and analysis device for researchers. The company has developed functional neuroimaging systems for preclinical neuroscience research and drug discovery industries. They have developed an imaging modality based on blood flow imaging. It enables to detection of neuronal activation in the whole brain.
- Oct 2022Grant (prize money)$1.2M
- Jan 2020Grant (prize money)$647.6K
#6
Acquired · Paris, Ile de France · founded 1993 · 2000 employees$903.7Kraised▾
Unithers is a contract manufacturing organization specializing in various dosage forms. Technologies offered include blow-fill seals, liquid stick packs, powder stick packs, effervescent tablets, pharmaceutical bottles, and suppositories and pessaries. The company claims to have R&D and manufacturing in Europe, a manufacturing facility in North America, and sales offices in Brazil.
- Oct 2022Series C—
- Dec 2021Grant (prize money)$903.7K
- Mar 2017Conventional Debt—
- Nov 2011Conventional Debt—
#7
Funding Raised · Paris, Ile de France · founded 2015$1.6Mraised▾
Provider of clinical research services for biopharma sector
- Sep 2020Grant (prize money)$807.8K
- Dec 2018Grant (prize money)$387.7K
- Jan 2018Grant (prize money)$417.9K
#8
Funding Raised · Paris, Ile de France · founded 1988 · 6000 employees$969Kraised▾
Delpharm provides contract manufacturing services for pharmaceutical products. It's product offering includes licensed products, generics, OTC products, dietary supplements, and veterinary products. The company has built capacity in various finished dosage forms including solid forms, such as tablets, pills, film coated tablets, effervescent, granulates, pouches, and capsules; semi-solid forms, including gels, creams, suppositories, and ointments; liquid forms, which include syrups, drops, ampoules, pouches, injected pouches, and vials; and specialty products that comprise cytotoxics, injectable steriles, biotechnologies, barium products, hormone gels, cell cultures, and diagnostic kits. It also offers various packaging solutions. The currently operate 10 manufacturing plants across various locations in France.
- Jun 2021Grant (prize money)$969K
- Feb 2016Conventional Debt—
- Jul 2011Conventional Debt—
- Jun 2011Conventional Debt—
#9
Funding Raised · Paris, Ile de France · founded 2006$311Kraised▾
Network supporting health innovation project development and funding. It provides access to public and private funding sources, facilitates partnerships among its members, and offers strategic guidance to accelerate project growth. The network assists in identifying potential collaborators and navigating the funding landscape. Support includes mentorship and resources throughout the project lifecycle.
- Sep 2022Grant (prize money)$16.4K
- Jul 2022Grant (prize money)$88.9K
- Jan 2018Grant (prize money)$87K
- Sep 2017Grant (prize money)$118.6K
#10
Seed · Paris, Ile de France · founded 2006 · 31 employees$765Kraised▾
XenTech’s claims to be one of the world’s largest and best characterized collection of Patient-Derived primary tumor Xenograft models (PDX).They are dedicated to the therapeutic development in Oncology by offering an innovative translational platform, developing clinically relevant tumor models and addressing the Biopharma industry's needs in preclinical oncology research. XenTech is a spin-off of the Institut Curie, France’s largest cancer research institute, where our scientists have conducted preclinical studies for over 15 years in collaboration with industrial and academic laboratories. They claim to have the world’s largest panel of breast cancer patient-derived xenografts and operate on a fee-for-service research contracts based business model
- Jan 2016Grant (prize money)$162.9K
- Nov 2008Seed$765K
#11
Funding Raised · Paris, Ile de France · founded 1990 · 13000 employees$316.6Kraised▾
Fareva Group is engaged in offering contract development manufacturing services for finished dosage forms and APIs. The company primarily has operations in Europe and USA. The therapeutic categories covered include anticancer, steroids, antivirals etc among others. They have capabilities to manufacture all types of dosage forms (Solid, semi-solid, liquid, and injectables, pastes, sterile injectables, suspensions, syrups, gels etc) and APIs (Highly potent APIs, steroids, hormones and antivirals)
- May 2021Grant (prize money)$316.6K
#12
Funding Raised · Paris, Ile de France · founded 2006$204.7Kraised▾
Provider of marketing consulting services for biopharma sector
- Dec 2019Grant (prize money)$204.7K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Paris is moving
A read on the academic research around Biotechnology in Paris — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 143 papers.
- AgroParisTech36
- Université Paris-Saclay33
- Université Paris Cité19
- Assistance Publique – Hôpitaux de Paris17
- CEA Paris-Saclay13
- Gene4
- Genome4
- Cell culture3
- DNA damage3
- Mutation3
- Disease1→3
- Selection (genetic algorithm)3
- Antibiotic resistance3
- Interferon3
- Food science3
- Gene3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.